• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种电子、无需监督的多发性硬化症扩展残疾状况量表患者报告版本。

An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis.

机构信息

UCSF MS Epic Study Group.

Plain Language Health, San Francisco, CA, USA.

出版信息

Mult Scler. 2021 Aug;27(9):1432-1441. doi: 10.1177/1352458520968814. Epub 2020 Nov 25.

DOI:10.1177/1352458520968814
PMID:33236967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8144241/
Abstract

BACKGROUND

In persons with multiple sclerosis (MS), the Expanded Disability Status Scale (EDSS) is the criterion standard for assessing disability, but its in-person nature constrains patient participation in research and clinical assessments.

OBJECTIVE

The aim of this study was to develop and validate a scalable, electronic, unsupervised patient-reported EDSS (ePR-EDSS) that would capture MS-related disability across the spectrum of severity.

METHODS

We enrolled 136 adult MS patients, split into a preliminary testing Cohort 1 ( = 50), and a validation Cohort 2 ( = 86), which was evenly distributed across EDSS groups. Each patient completed an ePR-EDSS either immediately before or after a MS clinician's Neurostatus EDSS evaluation.

RESULTS

In Cohort 2, mean age was 50.6 years (range = 26-80) and median EDSS was 3.5 (interquartile range (IQR) = [1.5, 5.5]). The ePR-EDSS and EDSS agreed within 1-point for 86% of examinations; kappa for agreement within 1-point was 0.85 ( < 0.001). The correlation coefficient between the two measures was 0.91 (<0.001).

DISCUSSION

The ePR-EDSS was highly correlated with EDSS, with good agreement even at lower EDSS levels. For clinical care, the ePR-EDSS could enable the longitudinal monitoring of a patient's disability. For research, it provides a valid and rapid measure across the entire spectrum of disability and permits broader participation with fewer in-person assessments.

摘要

背景

在多发性硬化症(MS)患者中,扩展残疾状况量表(EDSS)是评估残疾的标准,但它的现场性质限制了患者参与研究和临床评估。

目的

本研究旨在开发和验证一种可扩展的、电子的、无需监督的患者报告的 EDSS(ePR-EDSS),以捕捉整个严重程度范围内的 MS 相关残疾。

方法

我们招募了 136 名成年 MS 患者,分为初步测试队列 1(n=50)和验证队列 2(n=86),队列 2 患者的 EDSS 评分均匀分布在各个组。每位患者在接受 MS 临床医生的神经状态 EDSS 评估之前或之后完成一份 ePR-EDSS。

结果

在队列 2 中,平均年龄为 50.6 岁(范围=26-80),中位数 EDSS 为 3.5(四分位距(IQR)=[1.5, 5.5])。ePR-EDSS 和 EDSS 在 86%的检查中相差 1 分;1 分以内的一致性的kappa 值为 0.85(<0.001)。两种测量方法之间的相关系数为 0.91(<0.001)。

讨论

ePR-EDSS 与 EDSS 高度相关,即使在较低的 EDSS 水平也具有良好的一致性。对于临床护理,ePR-EDSS 可以实现患者残疾的纵向监测。对于研究,它提供了一种有效的、快速的衡量整个残疾范围的方法,并允许更广泛的参与,减少现场评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be3f/8144241/2a47d2096574/nihms-1680395-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be3f/8144241/7af769988aa6/nihms-1680395-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be3f/8144241/2a47d2096574/nihms-1680395-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be3f/8144241/7af769988aa6/nihms-1680395-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be3f/8144241/2a47d2096574/nihms-1680395-f0002.jpg

相似文献

1
An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis.一种电子、无需监督的多发性硬化症扩展残疾状况量表患者报告版本。
Mult Scler. 2021 Aug;27(9):1432-1441. doi: 10.1177/1352458520968814. Epub 2020 Nov 25.
2
Symptom-Level Disability Status Assessed with an Electronic Unsupervised Patient-Reported Expanded Disability Status Scale (ePR-EDSS) in Multiple Sclerosis Patients-The Example of Croatia.采用电子无监督患者报告扩展残疾状态量表(ePR-EDSS)评估多发性硬化症患者的症状水平残疾状况——以克罗地亚为例。
J Clin Med. 2022 Jul 14;11(14):4081. doi: 10.3390/jcm11144081.
3
Spanish validation of the telephone assessed Expanded Disability Status Scale and Patient Determined Disease Steps in people with multiple sclerosis.西班牙验证电话评估多发性硬化症患者扩展残疾状况量表和患者确定疾病步骤。
Mult Scler Relat Disord. 2019 Jan;27:333-339. doi: 10.1016/j.msard.2018.11.018. Epub 2018 Nov 19.
4
Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis.实现低成本、家庭式、远程医疗支持的多发性硬化症残疾评估。
Mult Scler. 2019 Oct;25(11):1526-1534. doi: 10.1177/1352458518793527. Epub 2018 Aug 24.
5
Expanded disability status scale by phone BR: Brazilian Portuguese validation.电话使用扩展残疾状况量表 BR:巴西葡萄牙语验证。
Mult Scler Relat Disord. 2024 Feb;82:105388. doi: 10.1016/j.msard.2023.105388. Epub 2023 Dec 16.
6
Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study.神经状态电子评分提高了扩展残疾状况量表评估的一致性:概念验证研究。
Mult Scler. 2017 Apr;23(4):597-603. doi: 10.1177/1352458516657439. Epub 2016 Jul 11.
7
Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disability.护士主导的对高度残疾的多发性硬化症患者进行扩展残疾状态量表评估的电话评估。
J Neurol Sci. 2016 Mar 15;362:66-8. doi: 10.1016/j.jns.2016.01.011. Epub 2016 Jan 6.
8
Electronic Neurostatus-EDSS increases the quality of expanded disability status scale assessments: Experience from two phase 3 clinical trials.电子神经状态-EDSS 提高了扩展残疾状况量表评估的质量:来自两项 3 期临床试验的经验。
Mult Scler. 2020 Jul;26(8):993-996. doi: 10.1177/1352458519845108. Epub 2019 May 7.
9
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.患者报告的扩展残疾状态量表工具的比较分析
Mult Scler. 2016 Sep;22(10):1349-58. doi: 10.1177/1352458515616205. Epub 2015 Nov 12.
10
Walking function in clinical monitoring of multiple sclerosis by telemedicine.通过远程医疗对多发性硬化症进行临床监测时的行走功能
J Neurol. 2015 Jul;262(7):1706-13. doi: 10.1007/s00415-015-7764-x. Epub 2015 May 10.

引用本文的文献

1
From checkboxes to emojis: a novel approach to patient-reported outcomes in multiple sclerosis.从复选框到表情符号:一种用于多发性硬化症患者报告结局的新方法。
J Neurol. 2025 May 30;272(6):434. doi: 10.1007/s00415-025-13169-y.
2
The epidemiology, pathology and pathogenesis of MS: Therapeutic implications.多发性硬化症的流行病学、病理学及发病机制:治疗意义
Neurotherapeutics. 2025 Feb 27:e00539. doi: 10.1016/j.neurot.2025.e00539.
3
MyMS: An Interface for Patient-Reported Outcomes for Finnish Individuals With Multiple Sclerosis.MyMS:芬兰多发性硬化症患者自我报告结果的界面

本文引用的文献

1
We should monitor our patients with wearable technology instead of neurological examination - Yes.我们应该使用可穿戴技术来监测我们的患者,而不是进行神经学检查——是的。
Mult Scler. 2020 Aug;26(9):1024-1026. doi: 10.1177/1352458520922762. Epub 2020 Jun 17.
2
A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and Development.一种用于多发性硬化症患者的精准医疗工具(开放式MS生物筛查):以人为本的设计与开发。
J Med Internet Res. 2020 Jul 6;22(7):e15605. doi: 10.2196/15605.
3
Development and validation of the self-reported disability status scale (SRDSS) to estimate EDSS-categories.
Int J MS Care. 2024 Oct 7;26(Q4):273-280. doi: 10.7224/1537-2073.2023-082. eCollection 2024 Oct.
4
Pragmatic phase II clinical trial to improve depression care in a real-world diverse MS cohort from an academic MS centre in Northern California: MS CATCH study protocol.加利福尼亚北部一所学术性多发性硬化症(MS)中心改善现实世界中多样化 MS 队列中抑郁护理的实用 II 期临床试验:MS CATCH 研究方案。
BMJ Open. 2024 Feb 24;14(2):e077432. doi: 10.1136/bmjopen-2023-077432.
5
"Self-care selfies": Patient-uploaded videos capture meaningful changes in dexterity over 6 months.“自我护理自拍”:患者上传的视频在 6 个月内捕捉到手部灵巧度的显著变化。
Ann Clin Transl Neurol. 2023 Dec;10(12):2394-2406. doi: 10.1002/acn3.51928. Epub 2023 Oct 25.
6
Remote Observational Research for Multiple Sclerosis: A Natural Experiment.远程观察性多发性硬化症研究:自然实验。
Neurol Neuroimmunol Neuroinflamm. 2022 Dec 30;10(2). doi: 10.1212/NXI.0000000000200070. Print 2023 Mar.
7
Clinical and Research Applications of the Electronic Medical Record in Multiple Sclerosis: A Narrative Review of Current Uses and Future Applications.电子病历在多发性硬化症中的临床与研究应用:当前用途及未来应用的叙述性综述
Int J MS Care. 2022 Nov-Dec;24(6):287-294. doi: 10.7224/1537-2073.2022-066. Epub 2022 Nov 15.
8
Symptom-Level Disability Status Assessed with an Electronic Unsupervised Patient-Reported Expanded Disability Status Scale (ePR-EDSS) in Multiple Sclerosis Patients-The Example of Croatia.采用电子无监督患者报告扩展残疾状态量表(ePR-EDSS)评估多发性硬化症患者的症状水平残疾状况——以克罗地亚为例。
J Clin Med. 2022 Jul 14;11(14):4081. doi: 10.3390/jcm11144081.
9
Effects of melatonin on sleep disturbances in multiple sclerosis: A randomized, controlled pilot study.褪黑素对多发性硬化症睡眠障碍的影响:一项随机对照试验性研究。
Mult Scler J Exp Transl Clin. 2021 Nov 5;7(4):20552173211048756. doi: 10.1177/20552173211048756. eCollection 2021 Oct.
自评残疾状况量表(SRDSS)的编制与验证,旨在评估 EDSS 类别。
Mult Scler Relat Disord. 2020 Jul;42:102148. doi: 10.1016/j.msard.2020.102148. Epub 2020 Apr 28.
4
Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis.远程监测连续评估步数与多发性硬化症成人残疾进展的关联。
JAMA Netw Open. 2019 Mar 1;2(3):e190570. doi: 10.1001/jamanetworkopen.2019.0570.
5
Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis.实现低成本、家庭式、远程医疗支持的多发性硬化症残疾评估。
Mult Scler. 2019 Oct;25(11):1526-1534. doi: 10.1177/1352458518793527. Epub 2018 Aug 24.
6
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.多发性硬化症的诊断:2017 年麦当劳标准修订版。
Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21.
7
Long-term evolution of multiple sclerosis disability in the treatment era.治疗时代多发性硬化症残疾的长期演变。
Ann Neurol. 2016 Oct;80(4):499-510. doi: 10.1002/ana.24747. Epub 2016 Aug 13.
8
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.患者报告的扩展残疾状态量表工具的比较分析
Mult Scler. 2016 Sep;22(10):1349-58. doi: 10.1177/1352458515616205. Epub 2015 Nov 12.
9
Leveraging human-centered design in chronic disease prevention.在慢性病预防中运用以人为本的设计。
Am J Prev Med. 2015 Apr;48(4):472-9. doi: 10.1016/j.amepre.2014.10.014. Epub 2015 Feb 18.
10
Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis.验证一种新的基于网络的方法,以捕捉多发性硬化症中的疾病进展结果。
J Neurol. 2013 Oct;260(10):2505-10. doi: 10.1007/s00415-013-7004-1. Epub 2013 Jun 27.